Previous Article | Next Article ![]()
Infect Immun, July 1998, p. 3290-3294, Vol. 66, No. 7
Departments of
Vaccines1 and
Virology,2 National Public Health
Institute, 00300 Helsinki, Finland
Received 11 September 1997/Returned for modification 4 December
1997/Accepted 28 April 1998
A new pulmonary T-cell-like lymphocyte population with the
phenotype CD3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Expansion of a Novel Pulmonary CD3
CD4+
CD8+ Cell Population in Mice during Chlamydia
pneumoniae Infection
CD4+ CD8+ was
discovered in mice. CD4+ CD8+ but
CD3+ cells among murine intestinal intraepithelial
lymphocytes have previously been described. We describe herein a
dramatic expansion of the CD3
CD4+
CD8+ cell population in response to experimental
respiratory infection. After intranasal Chlamydia
pneumoniae infection, CD4+ CD8+ cells
became transiently the dominant lymphocyte type (maximum of 87% of all
lymphocytes) in the lungs of NIH/S mice but remained virtually
undetectable in spleen and blood. The enrichment of these cells was not
a C. pneumoniae-specific event, since infection of NIH/S
mice with influenza A virus also resulted in an increase in the number
of CD4+ CD8+ cells (maximum of 42% of all
lymphocytes). In addition to outbred NIH/S mice, two other mouse
strains were studied: BALB/c (H-2d) and C57BL/6
(H-2b). C. pneumoniae-infected BALB/c mice
responded with an intermediate increase in the number of
CD4+ CD8+ cells in lungs, whereas C57BL/6 mice
did not respond. The double-positive CD4+ CD8+
cells lacked a major part of the T-cell receptor complex, being both
CD3
and TCR 

. However, when they were
stimulated in vitro with a T-cell mitogen, they responded by
proliferation but did not secrete gamma interferon. The dramatic
expansion of this cell population at the infection site suggests an
active role for them in respiratory infection, but the specification of
this requires further study.
*
Corresponding author. Mailing address: Department of
Vaccines, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland. Phone: 358-9-4744 8565. Fax: 358-9-4744 8347. E-mail: nina.rautonen{at}ktl.fi.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»